Companies: 10,795·Total market cap: $144.5T
Zai Lab Limited

Zai Lab Limited

ZLABNASDAQHealthcare● Active
$16.53
$-0.09(-0.54%)
Market Cap$1.9B
P/E Ratio—
52W High$44.34
52W Low$15.96
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Zai Lab Limited (ZLAB) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001704292 · ZLAB · NASDAQ · as of Jun 8, 2026

Filing snapshot

701
Total Filings
4
Latest Form
2026-05-28
Most Recent
2017
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001704292 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-26
Fiscal Year End
Feb 26, 2026
Accession No.
0001704292-26-000015
Primary Document
zlab-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001704292 · Accession 0001704292-26-000015

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2020-12-29
View 6-K on SEC
8-KCurrent Report
8-K
2026-05-21Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-21
View
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
8-K
2026-05-07
View
ARSARS
ARS
2026-04-28
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-28
View
DEF 14AProxy Statement
DEF 14A
2026-04-28
View
PRE 14APRE 14A
PRE 14A
2026-04-17
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-06
View
10-KAnnual Report
10-K
2026-02-26
View
8-KCurrent Report
8-K
2026-02-26
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-10
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-05
View
Showing 1–15 of 352 filingsForm 4 / 144 hidden· 701 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001704292  |  Exchange: NASDAQ · Healthcare

Zai Lab Limited (NASDAQ: ZLAB) has submitted 701 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001704292, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Zai Lab Limited's most comprehensive regulatory disclosure. The most recent Zai Lab Limited 10-K was filed on 2026-02-26 for fiscal year ending 2026. Historical ZLAB 10-K annual reports are available from 2017 through 2026.

Investors researching Zai Lab Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
CNTA SEC Filings →LEGN SEC Filings →CDTX SEC Filings →APGE SEC Filings →SRRK SEC Filings →XENE SEC Filings →IRON SEC Filings →TARS SEC Filings →
→ ZLAB Financials→ ZLAB Earnings→ ZLAB Insider Trades

Frequently Asked Questions

ZLAB SEC Filings · 8 questions

Zai Lab Limited (ZLAB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 701 filings and access original documents at no cost. Zai Lab Limited's CIK is 0001704292.

ZLAB SEC filingsZai Lab Limited SEC documentsfind ZLAB 10-K